CAJ | 학술논문

目的：分析疏肝和胃汤治疗反流性食管炎的临床价值。方法：随机选取2013年1月-2014年1月收治的90例反流性食管炎患者，按照患者就诊时间分为治疗组和对照组，各45例。对照组实施常规西药治疗，治疗组在常规西药基础上联合使用疏肝和胃汤治疗，分析两组患者临床疗效。结果：治疗组总有效率为95.6%，对照组总有效率为84.4%；两组间对比，P<0.05。治疗组治疗期间未出现不良反应，对照组出现1例恶心，1例皮疹，经对症处理好转。结论：疏肝和胃汤治疗反流性食管炎疗效显著，可明显改善患者临床症状，临床价值高，值得肯定。
목적：분석소간화위탕치료반류성식관염적림상개치。방법：수궤선취2013년1월-2014년1월수치적90례반류성식관염환자，안조환자취진시간분위치료조화대조조，각45례。대조조실시상규서약치료，치료조재상규서약기출상연합사용소간화위탕치료，분석량조환자림상료효。결과：치료조총유효솔위95.6%，대조조총유효솔위84.4%；량조간대비，P<0.05。치료조치료기간미출현불량반응，대조조출현1례악심，1례피진，경대증처리호전。결론：소간화위탕치료반류성식관염료효현저，가명현개선환자림상증상，림상개치고，치득긍정。
Objective: To analyze clinical efficacy of the Shugan Hewei decoction on reflux esophagitis. Methods: 90 patients were divided into two groups based on hospitalitization time, 45 cases for each, the control group was given routine western medicine, and another was given the Shugan Hewei decoction more. Results: The total efficacy in the treatment group was 95.6%, obviously higher than 84.4% in the control,P<0.05. There was no adverse reaction in treatment group; while in the control group, 1 case of nausea and 1 case of rash were improved after symptomatic treatment. Conclusion: The Shugan Hewei decoction is good at treating reflux esophagitis, can significantly improve clinical symptoms with high clinical value, and is worthy of recognition.